Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Objective: The objective of this study was to conduct a retrospective, comprehensive assessment of calcium: phosphate metabolism, with particular emphasis on vitamin D status in patients with genetically confirmed hypophosphatasia (HPP), and to identify potential correlations between 25(OH)D concentrations and other parameters of calcium: phosphate in this group of patients.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Assessment of Vitamin D Status and Calcium: Phosphate Metabolism in Patients with Hypophosphatasia: A Single-Center Cohort Study

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Assessment of Vitamin D Status and Calcium-Phosphate Metabolism in Patients with Hypophosphatasia: A Single-Center Cohort Study

Cohort study · Nutrients · 2026

Original publication title

Assessment of Vitamin D Status and Calcium: Phosphate Metabolism in Patients with Hypophosphatasia: A Single-Center Cohort Study

Izabela Michałus; Marta Pejska; Aleksandra Jóźwiak-Markiewicz; Agnieszka Konopka; Ewa Starostecka; Aneta Gwozdowska; Arkadiusz Zygmunt

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Hypophosphatasia (HPP) is a rare genetic disorder caused by a loss-of-function mutation in the ALPL gene, which encodes tissue-nonspecific alkaline phosphatase (TNSALP). Reduced TNSALP activity in HPP primarily leads to bone mineralization disorders. Given the complex and challenging nature of issues related to vitamin D and HPP, it is essential to evaluate each patient individually and adjust the appropriate dose of vitamin D according to their specific needs in order to maintain calcium phosphate homeostasis and normal vitamin D levels. Maintaining proper vitamin D homeostasis in patients with hypophosphatasia is one of the greatest challenges.

Objective:

The objective of this study was to conduct a retrospective, comprehensive assessment of calcium: phosphate metabolism, with particular emphasis on vitamin D status in patients with genetically confirmed hypophosphatasia (HPP), and to identify potential correlations between 25(OH)D concentrations and other parameters of calcium: phosphate in this group of patients.

Methods:

A single-center, retrospective pilot study was conducted in a small cohort (n = 36) of patients suffering from an ultra-rare genetic disorder, hypophosphatasia. The small sample size reflects the ultra-rare nature of the disease; so far, HPP has been diagnosed in approximately 50 patients in Poland (prevalence 1:300,000). The analysis included medical records of patients.

Results:

Vitamin D deficiency was not observed in the majority of patients with hypophosphatasia in the study group. The initiation of long-term enzyme replacement therapy (with asfotase alfa) did not significantly affect the annual change in mean serum vitamin D concentration. As established in the literature, growth disorders are an inherent feature of the clinical picture of hypophosphatasia. This was reflected in our study group, where nearly half of the pediatric patients achieved a height below the 10th percentile.

Conclusions:

Within this limited sample, these growth issues did not appear to be associated with disturbances in calcium and phosphate metabolism or vitamin D deficiency.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

The objective of this study was to conduct a retrospective, comprehensive assessment of calcium: phosphate metabolism, with particular emphasis on vitamin D status in patients with genetically confirmed hypophosphatasia (HPP), and to identify potential correlations between 25(OH)D concentrations and other parameters of calcium: phosphate in this group of patients.

Source: Objective:

Abstract: Results

Vitamin D deficiency was not observed in the majority of patients with hypophosphatasia in the study group. The initiation of long-term enzyme replacement therapy (with asfotase alfa) did not significantly affect the annual change in mean serum vitamin D concentration. As established in the literature, growth disorders are an inherent feature of the clinical picture of hypophosphatasia. This was reflected in our study group, where nearly half of the pediatric patients achieved a height below the 10th percentile.

Source: Results:

Abstract: Conclusions

Within this limited sample, these growth issues did not appear to be associated with disturbances in calcium and phosphate metabolism or vitamin D deficiency.

Source: Conclusions:
Authors’ abstract

Background:

Hypophosphatasia (HPP) is a rare genetic disorder caused by a loss-of-function mutation in the ALPL gene, which encodes tissue-nonspecific alkaline phosphatase (TNSALP). Reduced TNSALP activity in HPP primarily leads to bone mineralization disorders. Given the complex and challenging nature of issues related to vitamin D and HPP, it is essential to evaluate each patient individually and adjust the appropriate dose of vitamin D according to their specific needs in order to maintain calcium phosphate homeostasis and normal vitamin D levels. Maintaining proper vitamin D homeostasis in patients with hypophosphatasia is one of the greatest challenges.

Objective:

The objective of this study was to conduct a retrospective, comprehensive assessment of calcium: phosphate metabolism, with particular emphasis on vitamin D status in patients with genetically confirmed hypophosphatasia (HPP), and to identify potential correlations between 25(OH)D concentrations and other parameters of calcium: phosphate in this group of patients.

Methods:

A single-center, retrospective pilot study was conducted in a small cohort (n = 36) of patients suffering from an ultra-rare genetic disorder, hypophosphatasia. The small sample size reflects the ultra-rare nature of the disease; so far, HPP has been diagnosed in approximately 50 patients in Poland (prevalence 1:300,000). The analysis included medical records of patients.

Results:

Vitamin D deficiency was not observed in the majority of patients with hypophosphatasia in the study group. The initiation of long-term enzyme replacement therapy (with asfotase alfa) did not significantly affect the annual change in mean serum vitamin D concentration. As established in the literature, growth disorders are an inherent feature of the clinical picture of hypophosphatasia. This was reflected in our study group, where nearly half of the pediatric patients achieved a height below the 10th percentile.

Conclusions:

Within this limited sample, these growth issues did not appear to be associated with disturbances in calcium and phosphate metabolism or vitamin D deficiency.

Publication and source details

Original title: Assessment of Vitamin D Status and Calcium: Phosphate Metabolism in Patients with Hypophosphatasia: A Single-Center Cohort Study

Izabela Michałus; Marta Pejska; Aleksandra Jóźwiak-Markiewicz; Agnieszka Konopka; Ewa Starostecka; Aneta Gwozdowska; Arkadiusz Zygmunt

Nutrients · 2026

* Correspondence: izabela.michalus@iczmp.edu.pl (I.M.); marta.pejska@iczmp.edu.pl (M.P.)© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Polish Mother’s Memorial Hospital: Research Institutehttps://ror.org/059ex7y15 This research was funded by the Polish Mother’s Memorial Hospital: Research Institute in Lodz. The APC was funded by the Polish Mother’s Memorial Hospital: Research Institute in Lodz.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-07T22:00:35+00:00

DOI: 10.3390/nu18193119 · PMC13667278